A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes.

<h4>Objective</h4>Both rapid-acting insulin analogs, insulin aspart and lispro, attenuate prandial glucose excursion compared with human soluble insulin. This trial was performed to study the pharmacokinetic and pharmacodynamic profiles of insulin aspart and insulin lispro in type 1 diabetic patient... View More